Skip to main content
Equibles

Steven E. Hyman, M.D.

Board Member

Korsana Biosciences, Inc. (KRSA)

Equibles does not estimate personal net worth.

Get an email with a short summary when Korsana Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get KRSA alerts

About Steven E. Hyman, M.D.

Steven E. Hyman, M.D. is recorded as Board Member at Korsana Biosciences, Inc. (KRSA) since July 25, 2022. Korsana Biosciences, Inc. reported in an 8-K filed September 11, 2026 that Steven E. Hyman, M.D. resigned as board of directors, effective September 8, 2026. Korsana Biosciences, Inc. reported in an 8-K filed July 26, 2022 that Steven E. Hyman, M.D. was appointed board of directors, effective July 25, 2022. Korsana Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Korsana Biosciences, Inc. includes Jonathan Violin, Ph.D. (CEO and Board Member), Regina M. Graul (CEO and Board Member), Tomas Kiselak (Chairman and Board Member) and 7 others.

“On September 8, 2026, Errol B. De Souza, Ph.D., Regina M. Graul, Ph.D., Peter M. Hecht, Ph.D., Michael Higgins, Steven E. Hyman, M.D. and Dina Katabi, Ph.D. resigned from the Company’s board of directors and its committees on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company’s operations, policies or practices.”
Korsana Biosciences, Inc. Form 8-K, filed September 11, 2026 · Read the filing
“Cyclerion Therapeutics, Inc. (the “Company”) has announced that Steven E. Hyman, M.D., was appointed to the Company’s board of directors (the “Board”) on July 25, 2022.”
Korsana Biosciences, Inc. Form 8-K, filed July 26, 2022 · Read the filing

Affiliation history

Company network

Leadership on record at Korsana Biosciences, Inc.

Recent activity